I-Mab Biopharma
IMAB
#4360
Rank
$0.97 B
Marketcap
$11.81
Share price
1.11%
Change (1 day)
-84.15%
Change (1 year)

Market capitalization of I-Mab Biopharma (IMAB)

Market cap: $0.97 Billion

As of July 2022 I-Mab Biopharma has a market cap of $0.97 Billion. This makes I-Mab Biopharma the world's 4360th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of I-Mab Biopharma from 2020 to 2022

Year Market cap Change
2022$0.97 B-74.23%
2021$3.78 B12.05%
2020$3.38 B

End of Day market cap according to different sources

On Jul 6th, 2022 the market cap of I-Mab Biopharma was reported to be:

$0.91 Billion
by Yahoo Finance
$0.96 Billion
by CompaniesMarketCap
$0.96 Billion
by Nasdaq
$0.96 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$1.91 B 96.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.02 B-97.11%๐Ÿ‡บ๐Ÿ‡ธ USA